Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Health - January, 2006
37 articles
- Feds Accuse Impath Big-Wig Of $260M Fraud Scheme
- In Blow To Sanofi, Judge Refuses To Bar Allegra Generics
- Asbestos Companies Eye Chapter 11 Emergence
- Future Looks Grim For Charitable Hospitals
- Damages Award Slashed in Laser Surgery Case
- Curbed At Home, India's Generic Makers Go Overseas
- Emory Fires Patent Suit At Biotech Co, Former Exec
- Tyco Suffers Again As Court Upholds $64.5M Judgment
- Tyco Shells Out $330M In Masimo Settlement
- Scrushy Bullied UBS To Join Bribery Scheme, Says Aide
- QLT Loses Again To Takeda Abbott In Cancer Drug Clash
- Besieged Medtronic Settles Heart Patent Dispute
- Bristol-Myers Braces For Blow In Class Action Suit
- Shire OKs Generic Version of Blockbuster Drug
- Teva's Latest ANDA Draws Fire
- Appeals Court Denies Med Student Co-Inventorship
- Medtronic In Hot Water Again Over Spine Patents
- Biotech Giants Find Cooperation More Lucrative
- Court Upholds Pfizer Patent For Norvasc
- Rare Victory For Generic Drug Industry In Patent Ruling
- SOX Whistle-Blowing Rules Don't Apply Outside U.S.
- Former Top Lawyer to Pay $3M In Fraud Settlement
- Genetics Companies End Patent Dispute Over HPV Test
- Tenet To Pay $215M To Settle Shareholder Suit
- Drug Makers Nervously Eye High Court On Generics
- SEC Probes Drug Trial Firm Accused Of Recklessness
- SEC Eyes Hedge Fund's Influence In Merger Talks
- Cephalon, Mylan Settle Patent Dispute Over Provigil
- Supreme Court Eyes Glaxo's Paxil Appeal
- Repligen Seeks To Block Launch Of Bristol-Myers Drug
- Damages In Little-Known Biotech Suit Reach Record Level
- Briefs In LabCorp Case Split Over Business Methods
- Generics Maker Suffers Blow In Eye Drug Ruling
- Scrushy Ordered To Repay $48M In Bonuses
- Patent Suits Break Decade-Old Trend, Drop In '05
- Baxter Launches At-Risk Generic During Appeal
- Scrushy Motion To Expand Shareholder Control Denied